Monitoring specific T-cell responses to melanoma vaccines: ELISPOT, tetramers, and beyond.
Gajewski
T F
TF
Department of Pathology and Department of Medicine, Section of Hematology/Oncology, The University of Chicago, Chicago, Illinois 60637, USA. tgajewsk@medicine.bsd.uchicago.edu
D018414:CD8-Positive T-Lymphocytes / Q000276:immunology; D019496:Cancer Vaccines / Q000276:immunology*; D005544:Forecasting; D006801:Humans; D008285:Major Histocompatibility Complex / Q000276:immunology; D008545:Melanoma / Q000517:prevention & control*; D010455:Peptides / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology*
D019496:Cancer Vaccines; D010455:Peptides